Also found in: Financial.
KGaAKommanditgesellschaft Auf Aktien (German: Limited partnership on shares; business entity)
Copyright 1988-2018, All rights reserved.
References in periodicals archive ?
This joint development program brings together Universal Display Corporation's expertise in leading-edge phosphorescent OLED emitters and the state-of-the-art transport materials from Merck KGaA, Darmstadt, Germany.
(NASDAQ: IMI) have approved the company's pending acquisition by German science and technology company Merck KGaA, Darmstadt, Germany, through its subsidiary EMD Group Holding II, Inc., the company said.
"This agreement is another illustration of how we aim to enrich our discovery engine with strategic technology-focused collaborations," said Belen Garijo, chief executive officer, healthcare, Merck KGaA. "Artificial intelligence is emerging as a pillar in the biopharmaceutical R&D model, giving us exponential opportunity to complement our existing expertise with further speed and better precision.
Germany-based Merck KGaA is collaborating with Iktos, a French start-up company specialised in artificial intelligence for new drug design, to further accelerate its drug discovery capabilities.
Immunicum AB (STO:IMMU.ST), a biomedical company engaged in the development of cancer immunotherapies, on Friday announced that it has entered into a collaboration agreement with Merck KGaA, Darmstadt, Germany, and Pfizer Inc (NYSE:PFE), to evaluate its lead product, ilixadencel, an off-the-shelf cell-based cancer immune primer, in combination with avelumab* a human anti-PD-L1 monoclonal antibody, in a planned multi-indication phase Ib/II clinical trial.
The new, expanded application laboratory at the Jinqiao site in Shanghai's Pudong district is the first application laboratory in China that Merck KGaA, Darmstadt, Germany, launched to deliver comprehensive, customized services for its quality products and to seek and foster creative collaboration with customers for new applications and formulations.
Merck KGaA, Darmstadt, Germany (OTC:MKKGY) is a science and technology company in healthcare, life science and performance materials, developing technologies in the areas of biopharmaceutical therapies for cancer and multiple sclerosis, scientific research and production systems, and liquid crystals for smartphones and LCD televisions.
About the Life Science Business of Merck KGaA, Darmstadt, Germany
In this consortium of partners, Merck KGaA, Darmstadt, Germany, responsible for leading the program, also brings the chemistry and manufacturing expertise, resources, and support related to praziquantel.
Merck KGaA has now taken this idea to patent a new printing method.
The Facebook profile of a company is an important marketing device, Merck KGaA said.